Marco Daoura, Principal (Strategic Consulting, Medical Devices, Digital Health and HealthIT), will attend HLTH 2021 on October 17 – 20 at the Boston Convention & Exhibition Center. His attendance at the event, which is “the preeminent event designed for the health industry, bringing together senior leaders to solve healthcare’s most pressing problems and realize the most promising opportunities to create health’s future” demonstrates LBG’s dedication to staying current on industry advancements and trends. Mr. Daoura has more than 20... Read More
Given the current COVID-19 pandemic, at this time Latham BioPharm Group has suspended event attendance.
LBG is pleased to announce that Dr. Bob Huebner, Principal Consultant, will participate in a panel at BioKansas’ Community Forum entitled “Accelerating Biologics: The Market Landscape and Engineering Advancements” on October 21. He was invited to speak about the current biologics landscape and the future direction of the industry before the panel begins. Dr. Huebner is an experienced biotechnologist with more than 30 years of experience with viral and microbiological pathogens and expertise in the biologics industry, pandemic preparedness, group management, and... Read More